These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 363650

  • 1. [Possibilities of immunotherapy in malignant melanoma].
    Lewis MG.
    Hautarzt; 1978 Dec; 29(12):619-24. PubMed ID: 363650
    [Abstract] [Full Text] [Related]

  • 2. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU, Mavligit GM, Reed R, Burgess MA, Gottlieb J, Hersh EM.
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [Abstract] [Full Text] [Related]

  • 3. [Development in the immunotherapy of malignant melanoma].
    Tritsch H.
    Hautarzt; 1976 Jan; 27(1):1-7. PubMed ID: 767300
    [Abstract] [Full Text] [Related]

  • 4. Immune response and non-specific immunotherapy in melanoma.
    El-Domeiri AA.
    Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN, Iavorskiĭ VV, Kadagidze ZG, Malaev SG, Kupin VI.
    Vopr Onkol; 1977 Mar; 23(8):27-33. PubMed ID: 906404
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A malignus melanoma immunterápiájának lehetoségei].
    Ladányi A.
    Magy Onkol; 2003 Mar; 47(1):113-7. PubMed ID: 12704464
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Immunotherapeutic possibilities for treatment of malignant melanomas].
    Kokoschka EM.
    Hautarzt; 1979 Dec; 30(12):656-61. PubMed ID: 317654
    [Abstract] [Full Text] [Related]

  • 11. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
    Mitchell MS, Mokyr MB, Davis JM.
    J Clin Invest; 1977 Jun; 59(6):1017-26. PubMed ID: 863999
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy in malignant melanomaa.
    Homes EC, Morton DL, Eilber FR, Golub SE, Sulit HL.
    Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
    [Abstract] [Full Text] [Related]

  • 13. Current concepts in the management of malignant melanoma.
    Lichtenfeld JL.
    Am J Med Sci; 1976 Nov; 272(2):185-95. PubMed ID: 1008080
    [No Abstract] [Full Text] [Related]

  • 14. Immunotherapeutic approaches for the treatment of malignant melanoma.
    Curiel-Lewandrowski C, Atkins MB.
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1553-63. PubMed ID: 11763157
    [Abstract] [Full Text] [Related]

  • 15. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H, Muth M.
    Z Hautkr; 1982 Feb 15; 57(4):294-7. PubMed ID: 7080583
    [No Abstract] [Full Text] [Related]

  • 16. Induction of peptide-specific immune response in patients with primary malignant melanoma of the esophagus after immunotherapy using dendritic cells pulsed with MAGE peptides.
    Ueda Y, Shimizu K, Itoh T, Fuji N, Naito K, Shiozaki A, Yamamoto Y, Shimizu T, Iwamoto A, Tamai H, Yamagishi H.
    Jpn J Clin Oncol; 2007 Feb 15; 37(2):140-5. PubMed ID: 17255158
    [Abstract] [Full Text] [Related]

  • 17. [Current results with surgery and adjuvant chemotherapy in malignant melanoma].
    Mechl Z, Kopecný J.
    Arch Geschwulstforsch; 1986 Feb 15; 56(5):367-71. PubMed ID: 2429631
    [Abstract] [Full Text] [Related]

  • 18. [DTIC in malignant melanoma: a perspective (author's transl)].
    Kokoschka EM.
    Wien Klin Wochenschr; 1978 Dec 22; 90(24):870-4. PubMed ID: 369152
    [Abstract] [Full Text] [Related]

  • 19. Progress of immunotherapy in the treatment of malignant melanoma.
    Ariyan S.
    Yale J Biol Med; 1975 Nov 22; 48(5):423-9. PubMed ID: 1108459
    [No Abstract] [Full Text] [Related]

  • 20. Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
    Wood WC, Cosimi AB, Carey RW, Kaufman SD.
    Surgery; 1978 Jun 22; 83(6):677-81. PubMed ID: 644461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.